Express & Expedited Shipping Service
USD $500.29
IndiaKisqali, also known by its generic name Ribociclib, is an oral medication used in combination with aromatase inhibitors for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR-positive, HER2-negative) breast cancer in postmenopausal women. It is specifically indicated for use in combination with letrozole as initial endocrine-based therapy or with an aromatase inhibitor after progression on endocrine therapy.
Kisqali works by inhibiting specific proteins (cyclin-dependent kinases 4 and 6) that are involved in cell division. By blocking these proteins, Kisqali helps to slow down or stop the growth of cancer cells. This targeted therapy is part of a comprehensive treatment strategy aimed at managing advanced breast cancer.
The recommended dosage of Kisqali is 600 mg (three 200 mg tablets) taken once daily for 21 consecutive days, followed by 7 days off treatment. It is important to take Kisqali at the same time each day and to follow your healthcare provider's instructions carefully.
Common side effects may include fatigue, nausea, vomiting, diarrhea, and decreased appetite. More serious side effects can occur, such as liver problems, low blood cell counts, and lung inflammation. Regular monitoring by a healthcare provider is essential to manage any potential adverse effects.
Kisqali can interact with other medications, which may affect how it works or increase the risk of serious side effects. Inform your healthcare provider about all medications you are currently taking, including over-the-counter drugs and supplements.
Women who are pregnant or breastfeeding should not use Kisqali, as it may harm the fetus or nursing infant. Effective contraception is recommended during treatment and for at least 3 weeks after the last dose.
Kisqali represents a significant advancement in the treatment of HR-positive breast cancer, providing patients with a targeted therapy option. Always consult with your healthcare provider for personalized medical advice and to determine if Kisqali is the right choice for your treatment plan.
Health Guides
Nov 02, 2026
ADHD medication monitoring tracks blood pressure, heart rate, body mass, appetite and sleep before treatment, during dose adjustments and throughout long-term care. For adults, NICE recommends pulse and blood pressure checks before and after each dose change, then every six months. The aim is to pre
Nov 01, 2026
Baricitinib safety depends on infection screening, blood tests, and prompt evaluation of new symptoms. The main concerns are serious infections, shingles, blood clots, cancer, and cardiovascular events. Blood counts, liver and kidney function, and cholesterol help guide treatment. Historical rheumat
Oct 27, 2026
Benign prostatic hyperplasia (BPH) is a noncancerous enlarged prostate. Alpha blockers ease urinary symptoms by relaxing muscle around the outlet, often within days to weeks. 5-alpha-reductase inhibitors (5-ARIs) shrink the prostate gradually and can reduce the risks of urinary retention and surgery
Oct 25, 2026
Oral cancer medication safety depends on following the prescribed schedule, protecting household members from exposure, and reporting symptoms promptly. Tablets should stay intact, caregivers should use disposable gloves, and food or medicine changes need an oncology pharmacist's review. At-home o
Oct 13, 2026
A COPD diagnosis often leads to several prescriptions, each with a different job. A rescue inhaler eases sudden breathing symptoms. Long-acting bronchodilators are taken daily to control breathlessness and reduce exacerbations. Inhaled corticosteroids may be prescribed for people with recurrent fla
Oct 07, 2026
A medicine that prevents a stroke can also increase surgical bleeding, while stopping it can raise the risk of a clot. Preparing medications before surgery requires a written, individualized plan, not a blanket instruction to stop daily prescriptions. The short answer: Give the surgical team a comp
Oct 04, 2026
Grapefruit can change how much medication reaches the bloodstream, even when the prescribed dose stays the same. Grapefruit drug interactions affect certain cholesterol, blood pressure, transplant, cancer, and allergy medicines, but the risk depends on the exact medicine. For some drugs, exposure ri
Sep 25, 2026
A pharmacy may hand over 12 tablets when a prescription calls for 30, then show the order as "filled" in its app. The missing 18 tablets still matter. A partial fill means the pharmacy supplied less than the prescription authorizes. Call the pharmacy to confirm what's left and when it can be dispens
Sep 21, 2026
Multiple daily doses turn an ordinary routine into a safety task. A missed tablet, an extra dose, or an over-the-counter product added without review can cause harm, especially for people managing heart disease, diabetes, transplants, epilepsy, or cancer treatment with prescription medications. A sa
Sep 18, 2026
The first dose is when a prescription label deserves careful attention. A first-time user should verify the patient, medication identity, strength, dosage form, route, timing, warnings, and storage directions before taking it. Before taking prescription medicine, use the medication label to confirm
